Dr. Lawrence P. Casalino, chief of the Division of Outcomes and Effectiveness Research and the Livingston Farrand Associate Professor of Public Health, organized and moderated a small, invitation-only meeting Jan. 14 in Washington D.C., to discuss a draft report written by Dr. Casalino and colleagues on reducing the costs of provider-payer interactions. The meeting was part of a Robert Wood Johnson Foundation project, led by Dr. Casalino as principal investigator, on reducing administrative costs. Attendance included leaders from the National Coordinator for Health Information Technology, the Centers for Medicare and Medicaid Services, health care and health insurance professionals and Susan Dentzer, editor-in-chief of Health Affairs.
Dr. Nathaniel Hupert, associate professor of public health and associate professor of medicine, became chief editor of Emerging Health Threats Journal, an international open-access, peer-reviewed journal of research and policy focusing on the detection and management of evolving threats to global health and welfare, in January.
Dr. Francis Lee, professor of psychiatry and professor of pharmacology, was elected a member of the American College of Neuropsychopharmacology, effective Jan. 1. The College is the nation's premier professional society in brain, behavior and psychopharmacology research. In addition, Dr. Lee will be the Ruth K. and Shepard Broad Foundation Seminar Speaker April 2 at Duke University. The seminar series from the Broad Foundation at Duke seeks to promote translational neuroscience by facilitating the interactions of fundamental and clinical neuroscientists.
A paper by Dr. Nathan Thoma, clinical instructor of psychology in psychiatry, Dr. Barbara Milrod, professor of psychiatry, Dr. Anna Edwards, clinical instructor of psychology in psychiatry, Dr. James Kocsis, professor of psychiatry, and colleagues was rated one of the 10 most important of 2012 by the American Journal of Psychiatry. The paper, titled "A Quality-Based Review of Randomized Controlled Trials of Cognitive-Behavioral Therapy for Depression: An Assessment and Metaregression," examined the methodological quality of each of the 120 randomized controlled trials of cognitive-behavioral therapy for depression.
Submit your awards and honors to WCMCAwards@med.cornell.edu.